Ugur Eskiocak

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multispecific binding constructs against checkpoint molecules and u...
- Patent number 11,970,538
- Issue date Apr 30, 2024
- COMPASS THERAPEUTICS LLC
- Bing Gong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD137 antibodies and tumor antigen-targeting antibodies and uses th...
- Patent number 11,851,497
- Issue date Dec 26, 2023
- Compass Therapeutics LLC
- Robert V. Tighe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 11,752,207
- Issue date Sep 12, 2023
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD137 antibodies and PD-1 antagonists and uses thereof
- Patent number 11,718,679
- Issue date Aug 8, 2023
- Compass Therapeutics LLC
- Ugur Eskiocak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific binding constructs against checkpoint molecules and u...
- Patent number 11,046,769
- Issue date Jun 29, 2021
- COMPASS THERAPEUTICS LLC
- Bing Gong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,716,851
- Issue date Jul 21, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,434,175
- Issue date Oct 8, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,350,292
- Issue date Jul 16, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,039
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,040
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,038
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...
- Publication number 20240262914
- Publication date Aug 8, 2024
- Compass Therapeutics, LLC
- Bing GONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20240181050
- Publication date Jun 6, 2024
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF
- Publication number 20240002525
- Publication date Jan 4, 2024
- Compass Therapeutics LLC
- Ugur Eskiocak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS
- Publication number 20230331799
- Publication date Oct 19, 2023
- Xilio Development, Inc.
- Raphael ROZENFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MASKED IL-12 CYTOKINES AND THEIR CLEAVAGE PRODUCTS
- Publication number 20230159603
- Publication date May 25, 2023
- Xilio Development, Inc.
- Raphael ROZENFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MASKED IL-2 CYTOKINES AND THEIR CLEAVAGE PRODUCTS
- Publication number 20230151072
- Publication date May 18, 2023
- Xilio Development, Inc.
- Raphael ROZENFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-SPECIFIC CLEAVABLE LINKERS
- Publication number 20230072822
- Publication date Mar 9, 2023
- Xilio Development, Inc.
- Raphael ROZENFELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF MASKED CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CA...
- Publication number 20220340662
- Publication date Oct 27, 2022
- Xilio Development, Inc.
- Jennifer O'Neil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CANCER
- Publication number 20220306743
- Publication date Sep 29, 2022
- Xilio Development, Inc.
- Jennifer O'Neil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...
- Publication number 20210284736
- Publication date Sep 16, 2021
- Compass Therapeutics LLC
- Bing Gong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF
- Publication number 20210221902
- Publication date Jul 22, 2021
- Compass Therapeutics LLC
- Ugur Eskiocak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20200306374
- Publication date Oct 1, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND TUMOR ANTIGEN-TARGETING ANTIBODIES AND USES TH...
- Publication number 20200308293
- Publication date Oct 1, 2020
- Compass Therapeutics LLC
- Robert V. Tighe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...
- Publication number 20200181266
- Publication date Jun 11, 2020
- Compass Therapeutics LLC
- Bing Gong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20200046833
- Publication date Feb 13, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190269776
- Publication date Sep 5, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190224315
- Publication date Jul 25, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190125866
- Publication date May 2, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190099488
- Publication date Apr 4, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190060454
- Publication date Feb 28, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190015508
- Publication date Jan 17, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY

Ugur Eskiocak

Person

Patents Grantslast 30 patents

Multispecific binding constructs against checkpoint molecules and u...

CD137 antibodies and tumor antigen-targeting antibodies and uses th...

Agonist antibodies that bind human CD137 and uses thereof

CD137 antibodies and PD-1 antagonists and uses thereof

Multispecific binding constructs against checkpoint molecules and u...

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Patents Applicationslast 30 patents

MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF

MASKED IL-15 CYTOKINES AND THEIR CLEAVAGE PRODUCTS

MASKED IL-12 CYTOKINES AND THEIR CLEAVAGE PRODUCTS

MASKED IL-2 CYTOKINES AND THEIR CLEAVAGE PRODUCTS

TUMOR-SPECIFIC CLEAVABLE LINKERS

COMBINATION OF MASKED CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CA...

COMBINATION OF CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CANCER

MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...

CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

CD137 ANTIBODIES AND TUMOR ANTIGEN-TARGETING ANTIBODIES AND USES TH...

MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND U...

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF